David Protein, noted as one of the fastest-growing CPG brands in America, raised a $250m Series B at a $2.25bn valuation, per AgFunderNews.
ReadingThe steal: a valuation this size comes not from a great product but from a product that moves fast through a channel. If David Protein hit a $2.25bn valuation, they're either shipping to 20,000+ doors at 35%+ gross margin, or they've cracked DTC CAC below 15x LTV. For a protein product, that usually means: (1) high-frequency subscription (weekly or bi-weekly reorders), (2) wholesale placement in retailers where protein buyers already shop (Whole Foods, REI, specialty gyms), or (3) a viral story that lets word-of-mouth compress CAC. Run the math on your own business: LTV divided by CAC should be at least 3:1 for a VC-fundable model. If yours is below 2:1, you don't have a business yet — you have a marketing problem.
MY STASH TAKEA $2.25bn valuation in protein is a statement: the category is real, growth is accelerating, and there's room for a non-Gatorade player. David's Series B wasn't a rescue round — it was a growth round from a company with proof. The playbook here is boring: make a product that ships to people monthly without them thinking about it, get it into 5-10 retail chains that fit the buyer, and let the repeat purchase do the marketing. If you're in CPG and still thinking about investor decks before you've nailed unit repeat, you're building the wrong thing.
WatchWatch David Protein's next move into retail or subscription tiers — the Series B capital unlocks either distribution or marketing muscle.